Judge Cites Cert Grant In Keeping Lexapro Cases Alive

Law360, New York (July 25, 2008, 12:00 AM EDT) -- A federal judge on Thursday denied Forest Laboratories Inc.'s motion to dismiss 22 actions in the Celexa and Lexapro multidistrict litigation because of the U.S. Supreme Court's decision to grant certiorari in Levine v. Wyeth, which also deals with the question of federal preemption in product liability suits.

On July 18, Forest asked the U.S. District Court for the Eastern District of Missouri to dismiss close to half of the claims against the company in the suit because of conflict preemption.

That motion dealt only with...
To view the full article, register now.




Case Information

Case Title

In Re: Celexa and Lexapro Products Liability Litigation

Case Number



Missouri Eastern

Nature of Suit

Personal Inj. Prod. Liability


Rodney W. Sippel

Date Filed

February 17, 2006

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.